key: cord-0708673-j2l7o3va authors: Miller, Rhiannon C.; Stewart, Claire R.; Lipner, Shari R. title: Retrospective study of trends in dermatology telemedicine and in-person visits at an academic center during COVID-19 date: 2020-11-19 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.11.015 sha: 4a53856dfa8ea1de47d59b126b7e260f55d824dc doc_id: 708673 cord_uid: j2l7o3va nan Retrospective study of trends in dermatology telemedicine and inperson visits at an academic center during COVID-19 To the Editor: Many dermatologists have encountered difficulties providing timely in-person appointments during the COVID-19 pandemic because of social distancing requirements. While telemedicine may be effectively used for dermatologic care, triaging patients for in-person visits (IPVs) versus video visits (VVs) has not been adequately studied. 1 Our objectives were to analyze the characteristics of in-person and telemedicine dermatology visits to determine effective appointment allocation. In accordance with New York Stateemandated closures beginning March 22, 2020, Weill Cornell Dermatology limited in-person visits from March 23 through June 1 for patients requiring immediate inperson care. Patient visits March 16 through May 5 were queried from EPIC after institutional review board approval. All IPVs and VVs were sorted and ordered randomly. IPVs after VV triage were excluded. A total of 250 charts (50 IPVs and 200 VVs) were analyzed. Patients presenting for IPVs versus VVs were on average older (54.1 vs 39.6 years of age), Medicareinsured (44% vs 16%), and had melanoma (10% vs 2.5%) and nonmelanoma skin cancer histories (26% vs 12%; all P \ .05). There were no significant differences in gender, home-to-clinic distance, and new versus established patients (Table I) . There were significantly greater proportions of benign nevi (14% vs 3.5%), actinic keratoses (14% vs 5.5%), seborrheic keratoses (22% vs 3.5%), disorders of skin sensation (8% vs 2%), and nonmelanoma skin cancer (12% vs 1.5%) diagnoses in IPVs compared with VVs (Table II) . IPVs were significantly more likely to present with chief complaints related to skin lesions (34% vs 18% in the VVs). Notably, a procedure was performed in 64% of IPVs. There was no significant difference in average medication number or type initiated or discontinued between the 2 visit types (Table II) . There were no differences in proportion of patients with follow-up visits or time to follow-up (Table I) . Only 8% of VV patients had in-person consultation within 60 days of their VV. For the majority of VVs (71%), an IPV was not recommended. Older adults may be overrepresented in IPVs versus VVs because skin cancers are more prevalent in older individuals and they may have more difficulties using telemedicine. Simplified connections, increased education, and house calls may be considered to improve their usage. 2 Median distance to clinic was lower for IPVs versus VVs in previous studies 3 ; therefore, our discrepant findings may be because of COVID-related safety concerns. Approximately twice as many chief complaints in IPVs versus VVs were for skin lesions. Telemedicine has lower diagnostic accuracy in identifying pigmented lesions and is inadequate in diagnosing precancerous versus cancerous J AM ACAD DERMATOL n 2020 1 lesions. 4,5 Therefore, patients with concerning lesions should be scheduled for IPVs for clinical examination, dermoscopy, and possibly obtaining a biopsy specimen. Limitations of this study include its single-center, retrospective design and the limited number of patients. We could not account for patients who temporarily relocated from their billing addresses. Outcomes were not analyzed, and this is an important topic for future study. Our findings indicate that diagnosis, treatment, and follow-up for most dermatologic conditions does not vary between IPVs and VVs. In-person dermatology appointments should be preferentially scheduled for examination of concerning skin lesions, full-body skin examination in patients with skin cancer history, and necessary procedures. A systematic review of the use of telemedicine in plastic and reconstructive surgery and dermatology Novel solutions for dermatologic care of geriatric patients and the role of the dermatology house call Healthcare service utilization under a new virtual primary care delivery model Diagnostic reliability of in-person versus remote dermatology: a meta-analysis Teledermoscopy in doubtful melanocytic lesions: is it really useful?